CN1814139A - Baidianling capsule - Google Patents
Baidianling capsule Download PDFInfo
- Publication number
- CN1814139A CN1814139A CN 200510127625 CN200510127625A CN1814139A CN 1814139 A CN1814139 A CN 1814139A CN 200510127625 CN200510127625 CN 200510127625 CN 200510127625 A CN200510127625 A CN 200510127625A CN 1814139 A CN1814139 A CN 1814139A
- Authority
- CN
- China
- Prior art keywords
- radix
- root
- parts
- fructus
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for curing leucoderma, prepared of the seventeen Chinese medicinal herbs: Eclipta, Notopterygium Root, Tuber Fleeceflower Root, Dahurian Angelica Root, Malaytea Scurfpea Fruit, Huangqin, Chinese Angelica, Danshen 15-20 shares, Sinkiang Arnebia Root, Fragrant Solomonseal Rhizome, Cortex Moutan, Dodder Seed, Tribulus Terrestris, Common Cnidium Fruit, Radix Notoginseng, Lightyellow Sophora Root, andliquorice root, and having functions of dispelling the wind and dredging meridian, promoting the blood circulation and removing blood stasis, norishing liver and kidney, catalyzing melanin synthesis, and has remarkable curative effect on leucoderma and characters of short period of treatment, high cure rate, and no toxicity and side effect.
Description
Technical field
The present invention relates to the leukodermic medicine of a kind of treatment.
Background technology
Vitiligo be a kind of be the disease of feature to occur posteriority depigmentation speckle on the skin.Still there is not specific short at present.The object of the present invention is to provide a kind of curative effect with treatment leucoderma disease fast, the cure rate height is difficult for the Chinese patent medicine of the advantage of recurrence, to remedy the deficiency of other drug technology.
Technical scheme
Medication preparation process of the present invention is: Herba Ecliptae 15-20 part, Rhizoma Et Radix Notopterygii 15-20 part, Radix Polygoni Multiflori 15-20 part, Radix Angelicae Dahuricae 15-20 part, Fructus Psoraleae 15-20 part, Radix Scutellariae 15-20 part, Radix Angelicae Sinensis 15-20 part, Radix Salviae Miltiorrhizae 15-20 part, Radix Arnebiae (Radix Lithospermi) 15-20 part, Rhizoma Polygonati Odorati 10-15 part, Cortex Moutan 10-15 part, field dobber 10-15 part, Fructus Tribuli 10-15 part, Fructus Cnidii 10-15 part, Radix Notoginseng 6-10 part, Radix Sophorae Flavescentis 6-10 part, Radix Glycyrrhizae 3-6 part.Ten seven flavor medicines are got the raw materials ready by the prescription proportioning, and the porphyrize powder is crossed the 100-160 mesh sieve altogether, fully behind the mix homogeneously, behind the medicated powder disinfection by ultraviolet light, incapsulates by 0.5 gram, gets patent medicine.
Baidianling capsule of the present invention is based on motherland's traditional medicine to pathogenetic understanding of vitiligo and Therapeutic Principle, and according to clinical experience for many years, all medicines cooperate, and the pathogenesis that hits can play the purpose of treatment primary disease.
Vitiligo is because ailment said due to cold or exposure is invaded skin, causes occlusion of the pores of skin, and venation is obstructed, QIYINLIANGXU with the passing of time, and stagnation of QI-blood, blood do not allow skin to form.Modern medicine thinks because of the tryrosinase system destruction in the melanocyte of skin, and can not form melanin, is that to occur posteriority depigmentation speckle on a kind of skin be the disease of feature.May be relevant with Nervous and Mental Factors, delayed ischemic neurological deficits, immunologic function and endocrine disturbance.Clearly in " on the correction of the errors of medical works volume, the logical blood activating decoction of stealing is controlled the disease order " by the saying of " the vitiligo blood stasis is in flesh side ", and the theory of " control wind and control blood earlier, oneself goes out the blood sector-style ".The leukodermic emphasis of treatment by Chinese herbs with microcirculation improvement, makes melanin new life at blood stasis dispelling.Control suitable dispelling wind and removing obstruction in the collateral, blood circulation promoting and blood stasis dispelling, liver and kidney tonifying.Logical hundred arteries and veins of Rhizoma Et Radix Notopterygii a surname in the prescription, dispelling wind and removing obstruction in the collateral, the skin of dispelling, the ailment said due to cold or exposure of blood system, on can reach the top, mountain peak, Zhou Kezhi flesh table; Radix Angelicae Dahuricae awakening consciousness, the wind that can loose dehumidifying; The Fructus Tribuli dispelling wind-evil and transforming calculus, the suppressing the hyperactive liver dissipating depression of QI is controlled the skin pruritus due to wind pathogen; The Radix Sophorae Flavescentis heat clearing and damp drying, wind dispelling insecticide is still controlled whole body pruritus due to wind pathogen, and the various skin disease is all had good effect; Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling, the promoting the circulation of blood collateral dredging; Radix Arnebiae (Radix Lithospermi), Cortex Moutan clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling; Radix Scutellariae, Radix Glycyrrhizae QI invigorating help blood capable, and blood stasis is clear and mechanism of qi is smooth, and stasis is separated; Herba Ecliptae, Radix Polygoni Multiflori, Rhizoma Polygonati Odorati invigorating the liver and kidney tonifying YIN blood; Fructus Psoraleae, field dobber, Fructus Cnidii reinforcing the kidney and supporting YANG, beneficial marrow.
Each medicine cooperation of we has dispelling wind and removing obstruction in the collateral, logical hundred arteries and veins of a surname, tonifying QI to promote blood circulation, blood circulation promoting and blood stasis dispelling, nourishing the liver and kidney, the effect of biochemical essence and blood.Experimentation shows that Herba Ecliptae, Cortex Moutan, Fructus Cnidii, Fructus Psoraleae, Radix Arnebiae (Radix Lithospermi), Rhizoma Polygonati Odorati etc. have activation to the key enzyme-tryrosinase in the dermal melanin biosynthetic process in recent years, and catalysis melanin is synthetic.All medicines cooperate, and the pathogenesis that hits can play the purpose for the treatment of primary disease.
The present invention can be made into any regular dosage form.For example, can be made into capsule.Adult's dose is generally every day three times, each four.
Embodiment one
Press following prescription weighting raw materials: Herba Ecliptae 15-20 part, Rhizoma Et Radix Notopterygii 15-20 part, Radix Polygoni Multiflori 15-20 part, Radix Angelicae Dahuricae 15-20 part, Fructus Psoraleae 15-20 part, Radix Scutellariae 15-20 part, Radix Angelicae Sinensis 15-20 part, Radix Salviae Miltiorrhizae 15-20 part, Radix Arnebiae (Radix Lithospermi) 15-20 part, Rhizoma Polygonati Odorati 10-15 part, Cortex Moutan 10-15 part, field dobber 10-15 part, Fructus Tribuli 10-15 part, Fructus Cnidii 10-15 part, Radix Notoginseng 6-10 part, Radix Sophorae Flavescentis 6-10 part, Radix Glycyrrhizae 3-6 part.Ten seven flavor medicines are got the raw materials ready by the prescription proportioning, and altogether the porphyrize powder is crossed the 100-160 mesh sieve, fully behind the mix homogeneously, behind the medicated powder disinfection by ultraviolet light, incapsulates by 0.5 gram and to get final product.
Embodiment two
15 parts of Herba Ecliptaes, 15 parts of Rhizoma Et Radix Notopterygiis, 15 parts of Radix Polygoni Multiflori, 15 parts of the Radixs Angelicae Dahuricae, 15 parts of Fructus Psoraleaes, 15 parts of Radix Scutellariae, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of Radix Arnebiae (Radix Lithospermi)s, 10 parts of Rhizoma Polygonati Odorati, 10 parts of Cortex Moutans, 10 parts of field dobbers, 10 parts of Fructus Tribulis, 10 parts of Fructus Cnidiis, 6 parts of Radix Notoginseng, 6 parts of Radix Sophorae Flavescentiss, 3 parts in Radix Glycyrrhizae.Ten seven flavor medicines are got the raw materials ready by the prescription proportioning, and altogether the porphyrize powder is crossed the 100-160 mesh sieve, fully behind the mix homogeneously, behind the medicated powder disinfection by ultraviolet light, incapsulates by 0.5 gram and to get final product.
Embodiment three
20 parts of Herba Ecliptaes, 20 parts of Rhizoma Et Radix Notopterygiis, 20 parts of Radix Polygoni Multiflori, 20 parts of the Radixs Angelicae Dahuricae, 20 parts of Fructus Psoraleaes, 20 parts of Radix Scutellariae, 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Rhizoma Polygonati Odorati, 15 parts of Cortex Moutans, 15 parts of field dobbers, 15 parts of Fructus Tribulis, 15 parts of Fructus Cnidiis, 10 parts of Radix Notoginseng, 10 parts of Radix Sophorae Flavescentiss, 6 parts in Radix Glycyrrhizae.Ten seven flavor medicines are got the raw materials ready by the prescription proportioning, and altogether the porphyrize powder is crossed the 100-160 mesh sieve, fully behind the mix homogeneously, behind the medicated powder disinfection by ultraviolet light, incapsulates by 0.5 gram and to get final product.
Obtained better curative effect in the practical application.100 routine patients are observed treatment, take medicine 10-15 of the present invention days after, obviously take effect, the white macula district becomes redness.Have the local pigment of 90% patient to recover fully normally, the area that the produce effects pigment recovers surpasses more than 80%.Serve on three courses of treatment, strengthen consolidating, its disease is no longer recurred.Clinical results: cure rate reaches 80%, and effective percentage reaches 90%.
Case one: patient Zhao, woman, 15 years old, student.3 * 3cm white speckle appears in head the year before, and once several families hospitalize 9 months, and 3 * 2cm white speckle appears in the forehead that sees before, and is invalid and treat to here.Looked into outside head, two white maculas of frons, there is the irregular point-like milky of form patch skin lesion at the back, does not have any subjective symptoms, examines to be vitiligo.It is oral that treatment gives Baidianling capsule, and each 4, every day three times.After one month, the white macula district becomes redness, and the point-like pigmented spots are arranged in the skin lesion pore, and after three months, it is normal that pigment recovers, after treatment after two months again, and cephalopathy is decreased size and is sent out blackening whole, follows up a case by regular visits to after 1 year, does not see recurrence.
Case two: patient Lee, the man, 34 years old, private prosecution was suffered from vitiligo before 3 years, did not ache and did not itch, and once was interrupted treatment, poor effect.Have a medical check-up: breast, the back 4 white macula skin lesion that differ in size, symmetry takes place, and that presses does not fade, and skin lesion is smooth, and many white speckle new lives that differ in size are arranged, and examines to be vitiligo (carrying out the phase).It is oral that treatment gives Baidianling capsule, each 4 examples, three times on the one.White after two months skin lesion becomes redness, and peripheral darkish complexion stigma piece partly disappears, and does not see that new skin lesion occurs.Again after two months, black skin lesion island appears in the bulk skin lesion, the complete obiteration of fritter white macula.Continued to take two months, white macula all disappears again.For preventing recurrence, be with 1 medicine course of treatment (three months) to consolidate.Visit after 2 years, do not see recurrence.
Claims (1)
- The leukodermic medicine of a kind of treatment, it is made up of following crude drug: Herba Ecliptae 15-20 part, Rhizoma Et Radix Notopterygii 15-20 part, Radix Polygoni Multiflori 15-20 part, Radix Angelicae Dahuricae 15-20 part, Fructus Psoraleae 15-20 part, Radix Scutellariae 15-20 part, Radix Angelicae Sinensis 15-20 part, Radix Salviae Miltiorrhizae 15-20 part, Radix Arnebiae (Radix Lithospermi) 15-20 part, Rhizoma Polygonati Odorati 10-15 part, Cortex Moutan 10-15 part, field dobber 10-15 part, Fructus Tribuli 10-15 part, Fructus Cnidii 10-15 part, Radix Notoginseng 6-10 part, Radix Sophorae Flavescentis 6-10 part, Radix Glycyrrhizae 3-6 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510127625 CN1814139A (en) | 2005-12-06 | 2005-12-06 | Baidianling capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510127625 CN1814139A (en) | 2005-12-06 | 2005-12-06 | Baidianling capsule |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1814139A true CN1814139A (en) | 2006-08-09 |
Family
ID=36906571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510127625 Pending CN1814139A (en) | 2005-12-06 | 2005-12-06 | Baidianling capsule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1814139A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101190270B (en) * | 2007-04-29 | 2010-05-19 | 李明君 | Both oral and external traditional Chinese medicinal powder preparation for synthetically treating leukoderma |
CN101940624A (en) * | 2010-09-01 | 2011-01-12 | 黑龙江省亨发药业有限公司 | Chinese medicinal lotion for treating vitiligo |
CN101199589B (en) * | 2007-12-13 | 2011-09-21 | 孙瑞龙 | Tincture medicament for treating face vifiligo |
CN101224241B (en) * | 2007-01-20 | 2011-11-23 | 成爱华 | Melanin regeneration pill |
CN102406712A (en) * | 2011-07-11 | 2012-04-11 | 李保明 | Traditional Chinese medicine pills for treating vitiligo |
CN101099799B (en) * | 2006-07-08 | 2012-10-31 | 成爱华 | Medicine for treating leucoderma by melanin regeneration |
CN104056086A (en) * | 2014-05-29 | 2014-09-24 | 卞永兴 | Traditional Chinese medicine for treating leucoderma |
-
2005
- 2005-12-06 CN CN 200510127625 patent/CN1814139A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101099799B (en) * | 2006-07-08 | 2012-10-31 | 成爱华 | Medicine for treating leucoderma by melanin regeneration |
CN101224241B (en) * | 2007-01-20 | 2011-11-23 | 成爱华 | Melanin regeneration pill |
CN101190270B (en) * | 2007-04-29 | 2010-05-19 | 李明君 | Both oral and external traditional Chinese medicinal powder preparation for synthetically treating leukoderma |
CN101199589B (en) * | 2007-12-13 | 2011-09-21 | 孙瑞龙 | Tincture medicament for treating face vifiligo |
CN101940624A (en) * | 2010-09-01 | 2011-01-12 | 黑龙江省亨发药业有限公司 | Chinese medicinal lotion for treating vitiligo |
CN101940624B (en) * | 2010-09-01 | 2014-12-10 | 黑龙江省亨发药业有限公司 | Chinese medicinal lotion for treating vitiligo |
CN102406712A (en) * | 2011-07-11 | 2012-04-11 | 李保明 | Traditional Chinese medicine pills for treating vitiligo |
CN102406712B (en) * | 2011-07-11 | 2014-04-16 | 李保明 | Traditional Chinese medicine pills for treating vitiligo |
CN104056086A (en) * | 2014-05-29 | 2014-09-24 | 卞永兴 | Traditional Chinese medicine for treating leucoderma |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101637585B (en) | Chinese herbal preparation for treating posirasis and preparation method thereof | |
CN1318044C (en) | Chinese herbal medicine prepn for strengthening kidney-Yang | |
CN1814139A (en) | Baidianling capsule | |
CN1739774A (en) | Spot eliminating and youthful looks preserving capsule | |
CN102210820A (en) | Chinese medicinal composition for treating leukemia | |
CN102225100A (en) | Chinese medicinal formulation for treating cardiovascular and cerebrovascular diseases and preparation process of products thereof | |
CN103212021A (en) | Traditional Chinese medicine composition used for treating chloasma | |
CN1810281A (en) | Externally applied medicine for preventing and treating piles and health briefs therewith | |
CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
CN102935185B (en) | Pills for treating neurasthenia and preparation method | |
CN101926857A (en) | Traditional Chinese medicinal liniment for treating vitiligo | |
CN1242778C (en) | Hemiplegia treating pill | |
CN101856455B (en) | Chinese medicament for treating psoriasis vulgaris | |
CN104225507A (en) | Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage | |
CN105535855A (en) | Traditional Chinese medicinal composition for treating hepatitis B and preparation method thereof | |
CN101721669A (en) | Traditional Chinese medicine composition for treating cold dampness type sciatica | |
CN105456924A (en) | Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof | |
CN1907345A (en) | Chinese traditional medicine composition for treating cerebral apoplexy | |
CN101912566B (en) | Traditional Chinese medicine for treating palpitation | |
CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof | |
CN101940657B (en) | Capsules for treating leucoderma and preparation method thereof | |
CN101843825B (en) | Chinese medicament for treating climacteric syndromes | |
CN101279069A (en) | Medicament composite for dredging channels and collaterals, and promoting blood-circulation and removing blood stasis, and method of preparing the same | |
CN101530598A (en) | Plaster used for hyperosteogeny | |
CN105663758A (en) | Folium artemisiae argyi containing traditional Chinese medicine composition for treating irregular menstruation and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
AD01 | Patent right deemed abandoned | ||
C20 | Patent right or utility model deemed to be abandoned or is abandoned |